A 28-Day Randomized, Placebo-Controlled, Double-Blind, Parallel Groups and Normative Comparison Study to Evaluate the Effect of SAGE-718 on Functioning Capacity in Participants with Huntington's Disease

13564718-CIH-202Open (affiliates only)A 28-Day Randomized, Placebo-Controlled, Double-Blind, Parallel Groups and Normative Comparison Study to Evaluate the Effect of SAGE-718 on Functioning Capacity in Participants with Huntington's Disease 718-CIH-202 NCT05358821IndustrialAdultTreatmentOtherAnderson, KarenGeorgetown University Medical Center; Lombardi Comprehensive Cancer CenterGUMC Huntington Disease Care Ed & Rsch Center2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>